260 related articles for article (PubMed ID: 17467226)
1. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study.
Kern P; Ramelet AA; Wütschert R; Hayoz D
J Vasc Surg; 2007 Jun; 45(6):1212-6. PubMed ID: 17467226
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins.
Kern P; Ramelet AA; Wutschert R; Mazzolai L
Dermatol Surg; 2011 Nov; 37(11):1590-4. PubMed ID: 21883648
[TBL] [Abstract][Full Text] [Related]
3. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias.
Ramelet AA
Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins.
Nootheti PK; Cadag KM; Magpantay A; Goldman MP
Dermatol Surg; 2009 Jan; 35(1):53-7; discussion 57-8. PubMed ID: 19067733
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.
Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999
[TBL] [Abstract][Full Text] [Related]
7. Compression versus sclerotherapy for patients with isolated refluxing reticular veins and telangiectasia: a randomized trial comparing quality-of-life outcomes.
Schul MW; Eaton T; Erdman B
Phlebology; 2011 Jun; 26(4):148-56. PubMed ID: 21422193
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy of telangiectasias: a painless two-step technique.
Kern P
Dermatol Surg; 2012 Jun; 38(6):860-4. PubMed ID: 22404250
[TBL] [Abstract][Full Text] [Related]
9. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment.
Levy JL; Elbahr C; Jouve E; Mordon S
Lasers Surg Med; 2004; 34(3):273-6. PubMed ID: 15022257
[TBL] [Abstract][Full Text] [Related]
10. Foam sclerotherapy of the saphenous veins: randomised controlled trial with or without compression.
Hamel-Desnos CM; Guias BJ; Desnos PR; Mesgard A
Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):500-7. PubMed ID: 20097585
[TBL] [Abstract][Full Text] [Related]
11. [Cryocompression sclerotherapy of reticular veins and teleangiectasias].
Bogachev VI; Kuznetsov MR; Lobanov VN; Turkin PI
Angiol Sosud Khir; 2018; 24(3):92-97. PubMed ID: 30321152
[TBL] [Abstract][Full Text] [Related]
12. Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers.
Brizzio E; Amsler F; Lun B; Blättler W
J Vasc Surg; 2010 Feb; 51(2):410-6. PubMed ID: 19879713
[TBL] [Abstract][Full Text] [Related]
13. [Telangiectasias associated with reticular veins. Sclerotherapy or combined sclerotherapeutic and surgical approach?].
Albanese V; Cavallaro G
Minerva Cardioangiol; 2002 Feb; 50(1):29-37. PubMed ID: 11830716
[TBL] [Abstract][Full Text] [Related]
14. [Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia].
Bogachev VI; Boldin BV; Turkin PI; Lobanov VN
Angiol Sosud Khir; 2019; 25(4):102-107. PubMed ID: 31855206
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of short-term compression after sclerotherapy for telangiectatic varicose veins.
Bayer A; Kuznik N; Langan EA; Recke A; Recke AL; Faerber G; Kaschwich M; Kleemann M; Kahle B
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):435-443. PubMed ID: 32502730
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lidocaine as an analgesic when added to hypertonic saline for sclerotherapy.
Bukhari RH; Lohr JM; Paget DS; Hearn AT; Cranley RD
J Vasc Surg; 1999 Mar; 29(3):479-83. PubMed ID: 10069912
[TBL] [Abstract][Full Text] [Related]
17. Treating telangiectasias: my method.
Ferrara F; Ferrara G
Minerva Cardioangiol; 2013 Apr; 61(2):221-7. PubMed ID: 23492605
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sclerotherapy, laser, and radiowave coagulation in treatment of lower extremity telangiectasias.
Tepavcevic B; Matic P; Radak D
J Cosmet Laser Ther; 2012 Oct; 14(5):239-42. PubMed ID: 23016533
[TBL] [Abstract][Full Text] [Related]
19. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
[TBL] [Abstract][Full Text] [Related]
20. In vivo biological effects of foam sclerotherapy.
Hamel-Desnos CM; Desnos PR; Ferre B; Le Querrec A
Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):238-45. PubMed ID: 21531587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
